← Leaderboards
John W Tierney
Vanderbilt University
$69,894
Attributed
$69,894
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46.8K · FY2022–23$50K$37.5K$25K$12.5K$0
'22
'23
Funding mix
By agency
NIH$69,894 · 1
By mechanism
F31$69,894 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Joyce Cheung-Flynn$1,374,867
- Satoru Eguchi$8,928,684
- Michael James Osgood$156,308
- Igor V Voskresensky$104,727
- Kavi Mehta$929,443
Others in their field
Other Rising Stars on “Acute”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Christopher J. Lindsell · Vanderbilt University Medical Center$8,536,327
- Michael E. Roth · Public Health Institute$8,201,777
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
Research focus
AcuteCessation Of LifeAffectAmputationAcrylic AcidAdverse EffectsAortaArteriesArtery OcclusionAtherosclerosisAngioplastyBalloon AngioplastyAntiproliferative DrugsBilateralBiological Adaptation To StressBiological AvailabilityBiological MarkersBioreactorsBlood FlowBlood VesselsBypassCathetersBackClinical Trials
Grant awards (2)
In vivo vascular delivery of an MK2 inhibitory peptide for the prevention of smooth muscle cell phenotype switch and intimal hyperplasia.$23,142
F31 · FY2023 · HL · contact PI
In vivo vascular delivery of an MK2 inhibitory peptide for the prevention of smooth muscle cell phenotype switch and intimal hyperplasia.$46,752
F31 · FY2022 · HL · contact PI